openPR Logo
Press release

Chronic Idiopathic Constipation Treatment Market Predicted to Reach USD 15.9 billion by 2030, Recording Over a ~7% CAGR Says, Transparency Market Research

03-05-2024 02:57 PM CET | Health & Medicine

Press release from: Transparency Market Research

Chronic Idiopathic Constipation Treatment Market Predicted

The Chronic Idiopathic Constipation (CIC) Treatment Market addresses a prevalent gastrointestinal condition affecting millions globally. Chronic Idiopathic Constipation, characterized by infrequent bowel movements and difficulty passing stools without an identifiable cause, significantly impacts individuals' quality of life. This market offers therapeutic solutions aimed at alleviating symptoms, promoting regular bowel movements, and improving overall gastrointestinal health for those affected by CIC.

Chronic Idiopathic Constipation Treatment market is estimated to attain a valuation of US$ 15.9 Bn by the end of 2030, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of ~7% during the forecast period, 2020-2030

Get a Sample Copy of the Chronic Idiopathic Constipation Treatment Market Research Report -https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=20537&utm_source=openpr_amitugare&utm_medium=openpr

The significant players operating in the global Chronic Idiopathic Constipation Treatment market are

Bayer AG, Allergan, Bausch Health, Sanofi, Takeda Pharmaceutical Company

Key Market Drivers: Several factors drive the growth and evolution of the Chronic Idiopathic Constipation Treatment Market:

Rising Global Prevalence: The increasing prevalence of chronic constipation worldwide, attributed to factors such as sedentary lifestyles, inadequate dietary fiber intake, and aging populations, fuels demand for effective treatment options and management strategies to address constipation symptoms.

Advancements in Treatment Options: Ongoing research and development efforts in gastroenterology lead to the discovery and development of novel treatment modalities for chronic constipation, including prescription medications, over-the-counter laxatives, dietary supplements, and behavioral therapies.

Growing Awareness and Diagnosis: Heightened awareness of chronic constipation among healthcare professionals and patients, coupled with improved diagnostic techniques and screening protocols, leads to earlier recognition and diagnosis of CIC, driving demand for appropriate treatment interventions.

Patient-Centric Care Models: Shifting healthcare paradigms toward patient-centered care models emphasize personalized treatment approaches that prioritize symptom relief, patient satisfaction, and adherence to therapy, fostering the development of tailored treatment regimens for individuals with CIC.

Buy this Premium Research Report: - https://www.transparencymarketresearch.com/checkout.php?rep_id=20537<ype=S

Recent Developments: Recent trends and developments in the Chronic Idiopathic Constipation Treatment Market include:

Introduction of Novel Therapeutics: Pharmaceutical companies introduce innovative prescription medications targeting specific mechanisms of action involved in bowel motility and transit, offering promising options for individuals with refractory or severe CIC symptoms.

Expansion of OTC Options: The availability of over-the-counter laxatives, stool softeners, and fiber supplements provides individuals with convenient and accessible treatment options for managing mild to moderate CIC symptoms without requiring a prescription.

Integration of Behavioral Therapies: Behavioral therapies, such as biofeedback therapy, cognitive-behavioral therapy (CBT), and gut-directed hypnotherapy, gain recognition as adjunctive treatments to pharmacological interventions, addressing the psychosocial aspects of chronic constipation and promoting long-term symptom management.

Regional Variation in Treatment Patterns: Regional disparities in healthcare infrastructure, cultural norms, and healthcare-seeking behaviors influence treatment utilization and preferences for chronic constipation management, leading to variations in treatment approaches and clinical outcomes across different geographic regions.

Market Segmentation -

Drug Class

Serotonin-4 (5-Ht4) Receptor Agonist
Prucalopride
Others
Guanylate Cyclase-C Agonist
Plecanatide
Linaclotide     
Laxatives
Sodium Picosulphate
Polycarbophil
Others
Stimulants
Bisacodyl
Senokot
Others
Others

Route of Administration
Oral
Rectal

Distribution Channel
Hospital Pharmacies   
Retail Pharmacies       
Online Pharmacies     

This Report lets you identify the opportunities in Chronic Idiopathic Constipation Treatment Market by means of a region:

North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
South America (Brazil etc.) The Middle East and Africa (North Africa and GCC Countries)

Reasons to Buy The Chronic Idiopathic Constipation Treatment Market Report: -

1.Regional report analysis highlighting the consumption of products/services in a region also shows the factors that influence the market in each region.

2.Reports provide opportunities and threats faced by suppliers in the Chronic Idiopathic Constipation Treatment industry around the world.

The report shows regions and sectors with the fastest growth potential.

3.A competitive environment that includes market rankings of major companies, along with new product launches, partnerships, business expansions, and acquisitions.

4.The report provides an extensive corporate profile consisting of company overviews, company insights, product benchmarks, and SWOT analysis for key market participants.

5.This report provides the industry's current and future market outlook on the recent development, growth opportunities, drivers, challenges, and two regional constraints emerging in advanced regions.

More Trending Reports by Transparency Market Research -

Acute Migraine Treatment Market- https://www.globenewswire.com/en/news-release/2023/08/18/2727843/32656/en/Acute-Migraine-Treatment-Market-Predicted-to-Reach-USD-7-billion-by-2031-Recording-Over-a-15-CAGR-Says-Transparency-Market-Research.html

Photodynamic Therapy Market- https://www.globenewswire.com/en/news-release/2023/07/17/2705951/32656/en/Photodynamic-Therapy-Market-to-Grow-at-a-CAGR-of-13-5-from-2022-to-2031-reaching-US-15-5-Billion-As-per-TMR-Study.html

About Us Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chronic Idiopathic Constipation Treatment Market Predicted to Reach USD 15.9 billion by 2030, Recording Over a ~7% CAGR Says, Transparency Market Research here

News-ID: 3413091 • Views:

More Releases from Transparency Market Research

Gas Compressor Market Outlook 2036: Global Industry Expected to Reach US$ 41.0 Billion by 2036 at 5.3% CAGR
Gas Compressor Market Outlook 2036: Global Industry Expected to Reach US$ 41.0 B …
The global gas compressor market was valued at US$ 23.2 Bn in 2025 and is projected to reach US$ 41.0 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. This steady growth trajectory reflects the structural importance of gas compression systems across upstream, midstream, and downstream gas value chains. Rising natural gas consumption, expansion of pipeline and LNG infrastructure, and national energy
Anesthesia Drugs Market to be Worth USD 12.6 Bn by 2036 - By Drug / By Application | U.S. • Germany • China • India
Anesthesia Drugs Market to be Worth USD 12.6 Bn by 2036 - By Drug / By Applicati …
The global anesthesia drugs market was valued at US$ 7.6 billion in 2025 and is projected to reach US$ 12.6 billion by 2036, expanding at a compound annual growth rate (CAGR) of 4.7% from 2026 to 2036. This steady growth trajectory reflects the essential and non-substitutable role of anesthesia drugs in modern healthcare systems. As surgical interventions continue to rise globally-across both elective and emergency procedures-the demand for safe, effective,
Single-Atom Catalysts Market Size is Expected to Expand from US$ 177.8 Million to US$ 1,000.2 Million by 2036 at a 17.0% CAGR
Single-Atom Catalysts Market Size is Expected to Expand from US$ 177.8 Million t …
The global single-atom catalysts (SACs) market is poised for remarkable growth as industries seek highly efficient, cost-effective, and sustainable catalytic solutions. Valued at US$ 177.8 million in 2025, the market is projected to reach US$ 1,000.2 million by 2036, expanding at a robust compound annual growth rate (CAGR) of 17.0% from 2026 to 2036. This rapid expansion reflects the growing importance of advanced catalysis in energy, chemicals, environmental protection, and
Non-specific Endonuclease Market to Reach USD 726.6 Million by 2036, Supported by Biopharma Growth
Non-specific Endonuclease Market to Reach USD 726.6 Million by 2036, Supported b …
The non-specific endonuclease market is witnessing steady growth, driven by the expanding use of molecular biology tools across biotechnology, pharmaceuticals, diagnostics, and academic research. Non-specific endonucleases are enzymes that cleave nucleic acids without requiring a specific recognition sequence, making them highly valuable for applications such as DNA/RNA degradation, sample preparation, viscosity reduction, and contamination control. Their broad activity profile differentiates them from restriction enzymes and enables versatile usage across multiple

All 5 Releases


More Releases for Treatment

Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value. View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview: The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025. Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any